Cargando…

Advantageous effects of immunosuppression with tacrolimus in comparison with cyclosporine A regarding renal function in patients after heart transplantation

BACKGROUND: Nephrotoxicity is a serious adverse effect of calcineurin inhibitor therapy in patients after heart transplantation (HTX). AIM: In this retrospective registry study, renal function within the first 2 years after HTX in patients receiving de novo calcineurin inhibitor treatment, that is,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Helmschrott, Matthias, Rivinius, Rasmus, Ruhparwar, Arjang, Schmack, Bastian, Erbel, Christian, Gleissner, Christian A, Akhavanpoor, Mohammadreza, Frankenstein, Lutz, Ehlermann, Philipp, Bruckner, Tom, Katus, Hugo A, Doesch, Andreas O
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2015
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346008/ https://www.ncbi.nlm.nih.gov/pubmed/25759566 http://dx.doi.org/10.2147/DDDT.S79343

Ejemplares similares

Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen
por: Helmschrott, Matthias, et al.
Publicado: (2014)

Analysis of malignancies in patients after heart transplantation with subsequent immunosuppressive therapy
por: Rivinius, Rasmus, et al.
Publicado: (2014)

Conversion to generic cyclosporine A in stable chronic patients after heart transplantation
por: Kraeuter, Maximilian, et al.
Publicado: (2013)

Long-term use of amiodarone before heart transplantation significantly reduces early post-transplant atrial fibrillation and is not associated with increased mortality after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2016)

COPD in patients after heart transplantation is associated with a prolonged hospital stay, early posttransplant atrial fibrillation, and impaired posttransplant survival
por: Rivinius, Rasmus, et al.
Publicado: (2018)

Elevated pre‐transplant pulmonary vascular resistance is associated with early post‐transplant atrial fibrillation and mortality
por: Rivinius, Rasmus, et al.
Publicado: (2020)

The influence of surgical technique on early posttransplant atrial fibrillation – comparison of biatrial, bicaval, and total orthotopic heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2017)

Effects of vildagliptin (Galvus®) therapy in patients with type 2 diabetes mellitus after heart transplantation
por: Gueler, Ibrahim, et al.
Publicado: (2013)

Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation
por: Doesch, Andreas O, et al.
Publicado: (2013)

Heart rate reduction for 36 months with ivabradine reduces left ventricular mass in cardiac allograft recipients: a long-term follow-up study
por: Doesch, Andreas O, et al.
Publicado: (2013)

Chronic digitalis therapy in patients before heart transplantation is an independent risk factor for increased posttransplant mortality
por: Rivinius, Rasmus, et al.
Publicado: (2017)

Comparison of posttransplant outcomes in patients with no, acute, or chronic amiodarone use before heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2017)

Constrictive Pericarditis in the Presence of Remaining Remnants of a Left Ventricular Assist Device in a Heart Transplanted Patient
por: Rivinius, R., et al.
Publicado: (2015)

Effects of oral valganciclovir prophylaxis for cytomegalovirus infection in heart transplant patients
por: Doesch, Andreas O, et al.
Publicado: (2012)

Renal function in heart transplant patients after switch to combined mammalian target of rapamycin inhibitor and calcineurin inhibitor therapy
por: Helmschrott, Matthias, et al.
Publicado: (2017)

CCL19 and CCL21 modulate the inflammatory milieu in atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014)

Correction to: Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2021)

Five-year results of heart rate control with ivabradine or metoprolol succinate in patients after heart transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Combined amiodarone and digitalis therapy before heart transplantation is associated with increased post‐transplant mortality
por: Rivinius, Rasmus, et al.
Publicado: (2020)

Adventitial inflammation and its interaction with intimal atherosclerotic lesions
por: Akhavanpoor, Mohammadreza, et al.
Publicado: (2014)

Inflammatory therapeutic targets in coronary atherosclerosis—from molecular biology to clinical application
por: Linden, Fabian, et al.
Publicado: (2014)

Inhibition of B7-1 (CD80) by RhuDex(®) reduces lipopolysaccharide-mediated inflammation in human atherosclerotic lesions
por: Doesch, Andreas O, et al.
Publicado: (2014)

CXCL4 Plasma Levels Are Not Associated with the Extent of Coronary Artery Disease or with Coronary Plaque Morphology
por: Erbel, Christian, et al.
Publicado: (2015)

Systematic RNA-interference in primary human monocyte-derived macrophages: A high-throughput platform to study foam cell formation
por: Domschke, Gabriele, et al.
Publicado: (2018)

Risk Factors, Treatment and Prognosis of Patients with Lung Cancer after Heart Transplantation
por: Heil, Karsten M., et al.
Publicado: (2021)

Transfemoral aortic valve replacement for severe aortic valve regurgitation in a patient with a pulsatile‐flow biventricular assist device
por: Gomes, Bruna, et al.
Publicado: (2018)

Left ventricular assist device implantation in left ventricular aneurysm: The turtleneck technique
por: Haidari, Zaki, et al.
Publicado: (2022)

Identification of Specific Coronary Artery Disease Phenotypes Implicating Differential Pathophysiologies
por: Krohn, Jona B., et al.
Publicado: (2022)

Newly acquired complete right bundle branch block early after heart transplantation is associated with lower survival
por: Rahm, Ann‐Kathrin, et al.
Publicado: (2021)

Oral Anticoagulants after Heart Transplantation—Comparison between Vitamin K Antagonists and Direct Oral Anticoagulants
por: Darche, Fabrice F., et al.
Publicado: (2023)

PARP inhibition in atherosclerosis and its effects on dendritic cells, T cells and auto-antibody levels
por: Erbel, C, et al.
Publicado: (2011)

Structural components for the development of a heart failure network
por: Luedike, Peter, et al.
Publicado: (2022)

Effect of Tacrolimus and Cyclosporine Immunosuppressants on Peripheral Nerve Regeneration: Systematic Review and Meta-analysis
por: Seixas, Stéphanie Farias, et al.
Publicado: (2022)

Atrial fibrillation before heart transplantation is a risk factor for post‐transplant atrial fibrillation and mortality
por: Darche, Fabrice F., et al.
Publicado: (2021)

Pre-transplant Type 2 Diabetes Mellitus Is Associated With Higher Graft Failure and Increased 5-Year Mortality After Heart Transplantation
por: Rivinius, Rasmus, et al.
Publicado: (2022)

Frequency, Risk Factors, and Clinical Outcomes of Late-Onset Atrial Flutter in Patients after Heart Transplantation
por: Rahm, Ann-Kathrin, et al.
Publicado: (2022)

Differential effects of the immunosuppressive calcineurin inhibitors cyclosporine-A and tacrolimus on ovulation in a murine model
por: Zakerkish, F, et al.
Publicado: (2021)

Surgical ventricular reconstruction for the treatment of advanced heart failure—return of the surgeons?
por: Rivinius, Rasmus, et al.
Publicado: (2023)

Biliary diseases in heart transplanted patients: a comparison between cyclosporine a versus tacrolimus-based immunosuppression
por: Stief, J, et al.
Publicado: (2009)

Calcineurin Inhibitors and Neutropenia: Is Cyclosporine Superior to Tacrolimus?
por: Duggal, Tanu, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p8gr5fj96a55cbon26ftc42mj7